SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 20-F - Notification of inability to timely file Form 20-F:
SEC Accession No. 0001144204-18-024457
Filing Date
2018-05-01
Accepted
2018-05-01 16:15:37
Documents
1
Period of Report
2017-12-31
Effectiveness Date
2018-05-01

Document Format Files

Seq Description Document Type Size
1 NT 20-F tv492685_nt20f.htm NT 20-F 20159
  Complete submission text file 0001144204-18-024457.txt   21395
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: NT 20-F | Act: 34 | File No.: 001-36288 | Film No.: 18795693
SIC: 2834 Pharmaceutical Preparations